171. Nature’s Balance Sheet: Kevin Webb Invests in Biodiversity with Superorganism

Episode notes

Kevin Webb, Managing Director of Superorganism, joins Erum and Karl to discuss why biodiversity is the next frontier for venture capital. After 15 years backing SaaS unicorns and marketplaces, Kevin made a radical pivot to launch a $25M fund focused exclusively on biodiversity-driven startups. In this conversation, Kevin breaks down why nature has been catastrophically undervalued in our economic systems, how his fund identifies venture-scale opportunities in everything from invasive species leather to AI-powered ecosystem monitoring, and why measuring biodiversity is infinitely harder than tracking carbon emissions. He shares portfolio highlights including companies turning Burmese pythons into luxury goods, explains why sea otters would make ideal board members, and reveals the cultural, technological, and regulatory shifts that could transform biodiversity from a conservation concern into a mainstream asset class within the next decade. This episode is essential listening for founders, investors, and anyone interested in the intersection of nature, technology, and capital. Grow Everything brings the bioeconomy to life.

• 186. N.Y. Tech Week Live Demo: Engineering the Future of Manufacturing with Roebling's Brentan Alexander72 / 100
• 185. Brick Happens: Chris Maurer of Redhouse Studio Redesigns Remote Living for Earth and Mars75 / 100
• 184. The Multiverse of Microbes: Henry Lee on Building Cultivarium and Training with Titans65 / 100
• 183. The American Biotech Blueprint: Senator Todd Young on Biodiversity as National Security
• 182. SynBioBeta 2026 Recap, It's Biologist Approved